These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25213064)

  • 1. Successful rapid tocilizumab desensitization in a patient with Still disease.
    Justet A; Neukirch C; Poubeau P; Arrault X; Borie R; Dombret MC; Crestani B
    J Allergy Clin Immunol Pract; 2014; 2(5):631-2. PubMed ID: 25213064
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful Slow Desensitization to Tocilizumab in a 15-Year-Old Patient.
    Cansever M; Şahin N; Dursun I; Geyik C; Düşünsel R; Bektaş Kut F; Tahan F
    J Investig Allergol Clin Immunol; 2018 Dec; 28(6):436-438. PubMed ID: 30530397
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful Infusion of Obinutuzumab by Desensitization: A Case of Anaphylactic Shock During Desensitization.
    Kim KW; Chung S; Lee SY; Yoon SS; Kang HR
    J Investig Allergol Clin Immunol; 2020; 30(6):457-459. PubMed ID: 32376522
    [No Abstract]   [Full Text] [Related]  

  • 4. Eculizumab hypersensitivity and desensitization in a toddler with atypical hemolytic uremic syndrome.
    Lo R; Alexander S; Moss J; Siddiqi A; Liu A
    J Allergy Clin Immunol Pract; 2019; 7(7):2409-2410. PubMed ID: 30946976
    [No Abstract]   [Full Text] [Related]  

  • 5. Effective Desensitization to Tocilizumab in Delayed Hypersensitivity Reaction.
    Cortellini G; Mascella F; Simoncelli M; Lippolis D; Focherini MC; Cortellini F; Cherubini C; Gavioli B; Ballardini G
    Pharmacology; 2018; 102(1-2):114-116. PubMed ID: 29953985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tocilizumab for the treatment of systemic juvenile idiopathic arthritis.
    Herlin T
    Expert Rev Clin Immunol; 2012 Aug; 8(6):517-25. PubMed ID: 22992145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adalimumab desensitization protocol in a patient with a generalized urticarial reaction and angioedema following adalimumab administration.
    Gutiérrez Fernández D; Foncubierta Fernández A; Anguita Carazo JL; Fernández Meléndez S; Fernández Anguita MJ; Medina Varo F
    J Investig Allergol Clin Immunol; 2014; 24(4):273-5. PubMed ID: 25219112
    [No Abstract]   [Full Text] [Related]  

  • 8. Tocilizumab for the treatment of juvenile idiopathic arthritis.
    Decelle K; Horton ER
    Ann Pharmacother; 2012 Jun; 46(6):822-9. PubMed ID: 22589451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful rapid rituximab desensitization for hypersensitivity reactions to monoclonal antibodies in a patient with rheumatoid arthritis: a remarkable option.
    Abadoglu O; Epozturk K; Atayik E; Kaptanoglu E
    J Investig Allergol Clin Immunol; 2011; 21(4):319-21. PubMed ID: 21721382
    [No Abstract]   [Full Text] [Related]  

  • 10. Positive basophil activation test following anaphylaxis to pertuzumab and successful treatment with rapid desensitization.
    González-de-Olano D; Morgado JM; Juárez-Guerrero R; Sánchez-Muñoz L; Letellez-Fernández J; Malón-Giménez D; Castells MC
    J Allergy Clin Immunol Pract; 2016; 4(2):338-40. PubMed ID: 26725157
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of pertuzumab and docetaxel desensitization in oncological patient; apropos of a case].
    Guerrero Bautista R; Chica Marchal A; García Simón MS; Ferris Villanueva E; Pérez Cañadas P; De Andrés Bautista M
    Farm Hosp; 2014 Nov; 38(6):491-3. PubMed ID: 25542663
    [No Abstract]   [Full Text] [Related]  

  • 12. Inclusion of omalizumab in a trastuzumab desensitization protocol.
    Barreiro-Fernández EM; Gil-Sierra MD; Briceño-Casado MDP; Martínez-Díaz C; Ríos-Sánchez E
    Farm Hosp; 2022 Mar; 46(3):199-201. PubMed ID: 36183214
    [No Abstract]   [Full Text] [Related]  

  • 13. Desensitisation overcomes rituximab- and tocilizumab-related immediate hypersensitivity in childhood.
    Demir S; Soyer O; Bilginer Y; Sag E; Sahiner UM; Buyuktiryaki B; Sekerel BE; Ozen S
    Clin Exp Rheumatol; 2020; 38(3):552-557. PubMed ID: 31820716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term treatment of systemic juvenile idiopathic arthritis with tocilizumab: results of an open-label extension study in Japan.
    Yokota S; Imagawa T; Mori M; Miyamae T; Takei S; Iwata N; Umebayashi H; Murata T; Miyoshi M; Tomiita M; Nishimoto N; Kishimoto T
    Ann Rheum Dis; 2013 Apr; 72(4):627-8. PubMed ID: 23204515
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk factors for hypersensitivity reactions to tocilizumab introduction in systemic juvenile idiopathic arthritis.
    Yasuoka R; Iwata N; Abe N; Kohagura T; Nakaseko H; Shimizu M; Kawabe S
    Mod Rheumatol; 2019 Mar; 29(2):324-327. PubMed ID: 29578355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful subcutaneous desensitization in a patient with allergy to ixekizumab.
    Jimenez RB; Vera DG; Rivera-Díaz R; Cortijo-Cascajares S; Ballesteros RM; Pastor MDCD
    J Allergy Clin Immunol Pract; 2018; 6(5):1761-1762. PubMed ID: 29439935
    [No Abstract]   [Full Text] [Related]  

  • 17. Multiple upper gastrointestinal perforations in a 15-year-old patient treated with tocilizumab.
    Pfeil J; Grulich-Henn J; Wenning D; Breil T; Günther P; Lutz T
    Rheumatology (Oxford); 2014 Sep; 53(9):1713-4. PubMed ID: 24625503
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful desensitization to natalizumab in a skin test--positive patient: a case report.
    Bignardi D; Ribizzi G; Voltolini S; Serrati C; Troise C
    Eur Ann Allergy Clin Immunol; 2012 Feb; 44(1):26-9. PubMed ID: 22519129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Castleman's disease: Rapid desensitization for hypersensitivity reaction to rituximab].
    Boin C; Lambert S; Thomann P; Aujoulat O; Kieffer P
    Rev Med Interne; 2016 Jun; 37(6):433-6. PubMed ID: 26415921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful adalimumab desensitization after generalized urticaria and rhinitis.
    Rodríguez-Jiménez B; Domínguez-Ortega J; González-Herrada C; Kindelan-Recarte C; Loribo-Bueno P; Garrido-Peño N
    J Investig Allergol Clin Immunol; 2009; 19(3):246-7. PubMed ID: 19610276
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.